
A neurological disorder causing uncomfortable sensations in the legs and an irresistible urge to move them, particularly during rest and in the evening.
Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a common neurological sensorimotor disorder characterized by an uncomfortable urge to move the legs, typically accompanied by unpleasant sensations. These symptoms occur primarily during periods of rest or inactivity, are worse in the evening and at night, and are at least temporarily relieved by movement. RLS significantly impairs quality of life by disrupting sleep onset and causing daytime fatigue, and is associated with depression and anxiety. It affects both sleep and daytime functioning.
RLS affects approximately 5-10% of adults in Western populations, with moderate to severe symptoms occurring in 2-3%. It is more common in women (about 2:1 ratio) and prevalence increases with age. RLS can begin at any age, including childhood, and tends to worsen over time. There is a strong genetic component, with about 50% of patients having an affected first-degree relative.
The exact cause of RLS is not fully understood, but it involves dysfunction in the brain's dopamine system and iron metabolism. Primary RLS appears to be genetic, with several risk genes identified. Secondary RLS can be caused by: iron deficiency (the most important modifiable factor), kidney failure/dialysis, pregnancy (temporary), neuropathy, certain medications (antihistamines, antidepressants, antipsychotics, anti-nausea drugs), caffeine and alcohol, and other medical conditions. The brain may have difficulty using iron even when blood levels appear normal.
An uncomfortable, sometimes irresistible need to move the legs. The urge is typically accompanied by or caused by unpleasant sensations in the legs.
Described variously as creeping, crawling, pulling, itching, tingling, burning, or 'pins and needles' feelings deep inside the legs. Some patients struggle to describe the sensation.
Symptoms begin or worsen during periods of inactivity such as sitting or lying down.
There is a distinct circadian pattern with symptoms being most severe in the late evening and night, often peaking around midnight.
Walking, stretching, or moving the legs provides temporary relief, but symptoms return when movement stops.
Difficulty falling asleep due to symptoms, and sometimes awakening during the night with recurrent symptoms.
While legs are most commonly affected, some patients also experience symptoms in the arms.
If you answer yes to any of these questions, consider consulting a sleep specialist:
RLS is diagnosed clinically based on the presence of four essential criteria. Blood tests are important to check iron levels and rule out secondary causes. Sleep studies may be done to assess for periodic limb movements.
Diagnosis requires all four criteria: urge to move legs with uncomfortable sensations, symptoms worse at rest, relief with movement, and symptoms worse in evening/night.
Serum ferritin and iron saturation should be checked. Low ferritin (below 50-75 ng/mL) is associated with RLS even if not frankly deficient.
Complete blood count, kidney function, thyroid function, and other tests may identify secondary causes.
Sleep study can document periodic limb movements in sleep (PLMS), which occur in about 80% of RLS patients. Not required for diagnosis.
The International RLS Study Group Rating Scale quantifies symptom severity and can track treatment response.
Treatment begins with addressing any underlying causes (especially iron deficiency) and triggers. Medications are used for more severe symptoms, but must be carefully managed to avoid 'augmentation' (worsening of symptoms over time).
If ferritin is below 50-75 ng/mL, iron supplementation (oral or IV) is first-line treatment. IV iron may be more effective and faster-acting.
Gabapentin enacarbil (Horizant), gabapentin, and pregabalin are first-line medications. They improve sensory symptoms and sleep without causing augmentation.
Pramipexole (Mirapex), ropinirole (Requip), and rotigotine patch are effective but carry significant risk of augmentation with long-term use. Used at low doses when needed.
For severe, refractory RLS, low-dose opioids (oxycodone, methadone) may be used carefully. Effective but require monitoring for dependence.
Discontinue or substitute medications that worsen RLS: antihistamines, most antidepressants (except bupropion), anti-nausea drugs, antipsychotics.
Managing kidney disease, neuropathy, and other conditions contributing to RLS.
Search our directory for sleep clinics that specialize in treating restless legs syndrome.
Search Clinics